Computational Toxicology of Chloroform: Reverse Dosimetry Using Bayesian Inference, Markov Chain Monte Carlo Simulation, and Human Biomonitoring Data

BACKGROUND One problem of interpreting population-based biomonitoring data is the reconstruction of corresponding external exposure in cases where no such data are available. OBJECTIVES We demonstrate the use of a computational framework that integrates physiologically based pharmacokinetic (PBPK) modeling, Bayesian inference, and Markov chain Monte Carlo simulation to obtain a population estimate of environmental chloroform source concentrations consistent with human biomonitoring data. The biomonitoring data consist of chloroform blood concentrations measured as part of the Third National Health and Nutrition Examination Survey (NHANES III), and for which no corresponding exposure data were collected. METHODS We used a combined PBPK and shower exposure model to consider several routes and sources of exposure: ingestion of tap water, inhalation of ambient household air, and inhalation and dermal absorption while showering. We determined posterior distributions for chloroform concentration in tap water and ambient household air using U.S. Environmental Protection Agency Total Exposure Assessment Methodology (TEAM) data as prior distributions for the Bayesian analysis. RESULTS Posterior distributions for exposure indicate that 95% of the population represented by the NHANES III data had likely chloroform exposures < or = 67 microg/L [corrected] in tap water and < or = 0.02 microg/L in ambient household air. CONCLUSIONS Our results demonstrate the application of computer simulation to aid in the interpretation of human biomonitoring data in the context of the exposure-health evaluation-risk assessment continuum. These results should be considered as a demonstration of the method and can be improved with the addition of more detailed data.

[1]  N. Metropolis,et al.  Equation of State Calculations by Fast Computing Machines , 1953, Resonance.

[2]  J. Hadamard Sur les problemes aux derive espartielles et leur signification physique , 1902 .

[3]  Harvey J Clewell,et al.  Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling , 2007, Journal of Exposure Science and Environmental Epidemiology.

[4]  R A Corley,et al.  Physiologically based pharmacokinetic modeling of the temperature-dependent dermal absorption of chloroform by humans following bath water exposures. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  Bradley P. Carlin,et al.  BAYES AND EMPIRICAL BAYES METHODS FOR DATA ANALYSIS , 1996, Stat. Comput..

[6]  Harvey J Clewell,et al.  Use of a Physiologically Based Pharmacokinetic Model to Identify Exposures Consistent With Human Biomonitoring Data for Chloroform , 2006, Journal of toxicology and environmental health. Part A.

[7]  A. Gelman,et al.  Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions , 1996 .

[8]  Harvey J Clewell,et al.  Use of Markov Chain Monte Carlo Analysis with a Physiologically‐Based Pharmacokinetic Model of Methylmercury to Estimate Exposures in U.S. Women of Childbearing Age , 2007, Risk analysis : an official publication of the Society for Risk Analysis.

[9]  D B Rubin,et al.  Markov chain Monte Carlo methods in biostatistics , 1996, Statistical methods in medical research.

[10]  John K Kruschke,et al.  Bayesian data analysis. , 2010, Wiley interdisciplinary reviews. Cognitive science.

[11]  M. Sohn,et al.  Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study , 2004, Journal of Exposure Analysis and Environmental Epidemiology.

[12]  L. Wallace Human Exposure and Body Burden for Chloroform and Other Trihalomethanes , 1997 .

[13]  K. Maurer,et al.  Third national health and nutrition examination survey , 1985 .

[14]  Don R. Maszle,et al.  MCSim: A Monte Carlo Simulation Program , 1997 .

[15]  Ken Sexton,et al.  Human Biomonitoring of Environmental Chemicals , 2004 .

[16]  I J Smeenk,et al.  Drinking water contaminants. , 1983, Environmental science & technology.

[17]  Harvey J Clewell,et al.  Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites. , 2006, Regulatory toxicology and pharmacology : RTP.

[18]  G Miller,et al.  Bayesian internal dosimetry calculations using Markov Chain Monte Carlo. , 2002, Radiation protection dosimetry.

[19]  Peter Green,et al.  Markov chain Monte Carlo in Practice , 1996 .

[20]  Harvey J Clewell,et al.  Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice. , 2006, Regulatory toxicology and pharmacology : RTP.

[21]  Harvey J Clewell,et al.  The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene. , 2007, Regulatory toxicology and pharmacology : RTP.

[22]  F. Jonsson Physiologically based pharmacokinetic modeling in risk assessment : Development of Bayesian population methods , 2001 .

[23]  Jason Bond,et al.  Interactive Correspondence Analysis in a Dynamic Object-Oriented Environment , 1997 .

[24]  P. Stolpman,et al.  Environmental Protection Agency , 2020, The Grants Register 2022.

[25]  F Y Bois,et al.  Statistical issues in toxicokinetic modeling: a bayesian perspective. , 2000, Environmental health perspectives.

[26]  Michael A. Gallo,et al.  Reconstruction of short-term multi-route exposure to volatile organic compounds using physiologically based pharmacokinetic models , 1994 .

[27]  C P Weisel,et al.  Studies of Multiroute Exposure/Dose Reconstruction Using Physiologically Based Pharmacokinetic Models 1 , 1996, Toxicology and industrial health.

[28]  W. K. Hastings,et al.  Monte Carlo Sampling Methods Using Markov Chains and Their Applications , 1970 .

[29]  M. Delp,et al.  Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.